Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.
Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, Ohsawa K, Higashi M, Nosaka K, Okuno Y, Tamaru JI, Mukasa A, Matsuoka M, Komohara Y.
Yano H, et al. Among authors: kai k.
Cancer Sci. 2022 Jun;113(6):2129-2143. doi: 10.1111/cas.15349. Epub 2022 Apr 8.
Cancer Sci. 2022.
PMID: 35343027
Free PMC article.